These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8338875)
41. Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino. Wu B; Lu P; Benrashid E; Malik S; Ashar J; Doran TJ; Lu QL Gene Ther; 2010 Jan; 17(1):132-40. PubMed ID: 19759562 [TBL] [Abstract][Full Text] [Related]
42. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice. Hoogaars WM; Mouisel E; Pasternack A; Hulmi JJ; Relizani K; Schuelke M; Schirwis E; Garcia L; Ritvos O; Ferry A; 't Hoen PA; Amthor H Hum Gene Ther; 2012 Dec; 23(12):1269-79. PubMed ID: 22894762 [TBL] [Abstract][Full Text] [Related]
43. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Kapsa R; Quigley A; Lynch GS; Steeper K; Kornberg AJ; Gregorevic P; Austin L; Byrne E Hum Gene Ther; 2001 Apr; 12(6):629-42. PubMed ID: 11426463 [TBL] [Abstract][Full Text] [Related]
44. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Liu F; Nishikawa M; Clemens PR; Huang L Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105 [TBL] [Abstract][Full Text] [Related]
45. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle. Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713 [TBL] [Abstract][Full Text] [Related]
47. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle. Kapsa RM; Wong SH; Quigley AF Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218 [TBL] [Abstract][Full Text] [Related]
48. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. Yanagihara I; Inui K; Dickson G; Turner G; Piper T; Kaneda Y; Okada S Gene Ther; 1996 Jun; 3(6):549-53. PubMed ID: 8789805 [TBL] [Abstract][Full Text] [Related]
49. Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Doran P; Wilton SD; Fletcher S; Ohlendieck K Proteomics; 2009 Feb; 9(3):671-85. PubMed ID: 19132684 [TBL] [Abstract][Full Text] [Related]
50. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector. Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108 [TBL] [Abstract][Full Text] [Related]
51. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869 [TBL] [Abstract][Full Text] [Related]
53. Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Doran P; Martin G; Dowling P; Jockusch H; Ohlendieck K Proteomics; 2006 Aug; 6(16):4610-21. PubMed ID: 16835851 [TBL] [Abstract][Full Text] [Related]
54. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts. Moisset PA; Gagnon Y; Karpati G; Tremblay JP Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339 [TBL] [Abstract][Full Text] [Related]
55. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610 [TBL] [Abstract][Full Text] [Related]
56. A canine minidystrophin is functional and therapeutic in mdx mice. Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277 [TBL] [Abstract][Full Text] [Related]
57. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers. Williams JH; Sirsi SR; Latta DR; Lutz GJ Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666 [TBL] [Abstract][Full Text] [Related]
58. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Gregorevic P; Allen JM; Minami E; Blankinship MJ; Haraguchi M; Meuse L; Finn E; Adams ME; Froehner SC; Murry CE; Chamberlain JS Nat Med; 2006 Jul; 12(7):787-9. PubMed ID: 16819550 [TBL] [Abstract][Full Text] [Related]
59. Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. Trivedi RA; Dickson G J Neurochem; 1995 May; 64(5):2230-8. PubMed ID: 7722508 [TBL] [Abstract][Full Text] [Related]